Latest news with #AnnualReport2024
Barnama
24-04-2025
- Business
- Barnama
ADB Deploys Nearly US$40 Bln For Development Across Asia And The Pacific In 2024
KUALA LUMPUR, April 24 (Bernama) -- The Asian Development Bank (ADB) committed US$24.3 billion (US$1 = RM4.39) from its own resources last year, alongside US$14.9 billion in cofinancing with its partners, to address a range of complex development challenges in Asia and the Pacific. In a statement issued today, the bank explained that the US$24.3 billion encompassed loans, grants, equity investments, guarantees, and technical assistance provided to both governments and the private sector. According to the ADB's Annual Report 2024, which was published today, the bank built on the one million direct jobs it generated in 2024 by committing US$4.8 billion through its private sector projects and programmes, a 28.5 per cent increase from 2023. The ADB also highlighted that its collaborations with governments, financial institutions, and investors have fostered enabling business environments, strengthened capital markets, and boosted trade. 'With our increased financial firepower and a sharper strategic focus, ADB is turning commitment into concrete results,' said ADB President Masato Kanda, adding that the bank is financing more affordable and efficient energy and transport systems, supporting a vibrant private sector that creates better-quality jobs, and strengthening basic services in education, health, and social protection. The report also outlined ADB's evolution towards becoming a larger, more effective development bank. 'Milestones include capital management reforms that will enable ADB to expand its operations by 50 per cent over the next decade, a major update to the institution's corporate strategy, and a record US$5 billion replenishment for the Asian Development Fund, ADB's largest source of grant financing for operations in its poorest and most vulnerable developing member countries (DMCs),' it said. In addition, ADB deployed a variety of financial and knowledge-based support during the year to enhance food production systems, reduce the damaging impacts of extreme weather events, and reverse environmental degradation and biodiversity loss. The bank also assisted DMCs in implementing critical reforms to improve public financial management, address fiscal risks, and promote social and economic development through better domestic resource mobilisation and budgeting.
Barnama
22-04-2025
- Health
- Barnama
Malaysia Charts Path To Regional Leadership In Clinical Trials
PUTRAJAYA, April 22 (Bernama) -- Malaysia achieved another remarkable year in sponsored clinical research, driven by strong momentum, innovation, and a growing global footprint, as highlighted in Clinical Research Malaysia's (CRM) Annual Report 2024. The achievement was officially unveiled on 21 April 2025 by Health Minister, YB Datuk Seri Dr Dzulkefly Ahmad. The report detailed 267 new sponsored clinical research studies initiated in Malaysia last year, bringing the total number of sponsored studies to over 2,500 since CRM's establishment in 2012.
Barnama
21-04-2025
- Health
- Barnama
Malaysia Records 267 Sponsored Clinical Research In 2024
PUTRAJAYA, April 21 (Bernama) -- Malaysia recorded a total of 267 sponsored clinical research last year, according to the Clinical Research Malaysia (CRM) Annual Report 2024 that was launched by Health Minister Datuk Seri Dr Dzulkefly Ahmad today. The achievement pushes the total number of sponsored clinical research studies conducted in Malaysia to over 2,500 since CRM's establishment in 2012. CRM, in a statement today, said Malaysia also gained significant momentum in early phase research, with five First-in-Human (FIH) studies awarded, the highest number in a single year since the launch of CRM's Phase 1 Realisation Project in 2016. 'These early-phase studies were conducted at the Sarawak General Hospital, an FIH-accredited site by the National Pharmaceutical Regulatory Agency (NPRA). 'These achievements reflect Malaysia's growing capabilities and proven track record in delivering global clinical trials with speed, quality and reliability,' CRM said. In line with CRM's Vision 2033 to establish Malaysia as the preferred hub for clinical research in the region, CRM has been spearheading strategic missions focused on talent development and ecosystem growth. One of its flagship initiatives, the CRM Centre of Excellence (CoE), has produced 30 graduate trainees equipped with foundational training in clinical research. Additionally, CRM, in partnership with the Health Ministry, is currently leading an ASEAN-level initiative to expand industry-sponsored clinical trials across Southeast Asia, a strategic move aimed at positioning the region as a competitive and collaborative destination for global research investment. 'Much of this agenda will also be highlighted and discussed during the CRM Trial Connect 2025, an annual international conference which will gather at least 1,000 clinical research stakeholders in Kuala Lumpur in May,' it added.
Yahoo
16-04-2025
- Business
- Yahoo
Canon Publishes Annual Report for the Year Ended Dec. 31, 2024
MELVILLE, N.Y., April 16, 2025 (GLOBE NEWSWIRE) -- Canon Inc., the parent company of Canon U.S.A., Inc., a leader in digital imaging solutions, announced that it has published the Annual Report 2024, a consolidated financial report summarizing its financial results for 2024. This report is designed to help shareholders, investors, and other stakeholders achieve a greater understanding of Canon. To view the annual report, please click here. To view the CEO message, please visit here. About Canon U.S.A., Inc. Canon U.S.A., Inc. is a leading provider of consumer, business-to-business, and industrial digital imaging solutions to the United States, Latin America, and the Caribbean markets. With approximately $28.5 billion in global revenue, its parent company, Canon Inc., as of 2024 has ranked in the top-10 for U.S. patents granted for 41 consecutive years. † Canon U.S.A. is dedicated to its Kyosei philosophy of social and environmental responsibility. To learn more about Canon, visit and connect with us on LinkedIn at † Based on patent counts issued by the United States Patent and Trademark Office and compiled by IFI CLAIMS Patent Services. CONTACT: Brian Bohl Canon U.S.A., Inc. 516-408-8214 bbohl@ in to access your portfolio
Yahoo
11-04-2025
- Business
- Yahoo
Raketech Publishes its Annual Report 2024
TRIQ I-IMSIDA IL-GZIRA, MT / / April 11, 2025 / Raketech (STO:RAKE) As of today, April 11, 2025, the Annual Report 2024 for Raketech Group Holding Plc is available on the company website: For more information, please contact: investor@ About Raketech Group Raketech is a leading online affiliate and content marketing company, with expertise in delivering comparison services for sports and gaming, online guides, communities, and social media products. Raketech guides sports and gaming enthusiasts to the best possible services, while also delivering high-quality traffic and leads to its partners. Raketech grows both organically and via acquisitions and operates its business in accordance with a clear framework for responsible affiliate marketing services. The company's shares are listed in Nasdaq First North Premier Growth Market with ticker RAKE. Carnegie Investment Bank AB (publ) is the company's Certified Adviser. For more information, visit Attachments Raketech Annual Report 2024 SOURCE: Raketech View the original press release on ACCESS Newswire Sign in to access your portfolio
